AmpliPhi Biosciences

AmpliPhi Biosciences is a biopharmaceutical company focused on developing an internally generated pipeline of natural viruses, known as bacteriophages (phages), for the treatment of bacterial infections. Phage therapy offers a unique and proven approach to treating a variety of bacterial infections, particularly drug-resistant strains commonly found in hospital settings. We have established a drug development and manufacturing platform designed to rapidly develop and produce a range of phage therapies.